| For: | Simon Y, Kessler SM, Gemperlein K, Bohle RM, Müller R, Haybaeck J, Kiemer AK. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis. World J Gastroenterol 2014; 20(47): 17839-17850 [PMID: 25548482 DOI: 10.3748/wjg.v20.i47.17839] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i47/17839.htm |
| Number | Citing Articles |
| 1 |
Zhicong Zhao, Jiaxiang Meng, Rui Su, Jun Zhang, Jianjun Chen, Xiong Ma, Qiang Xia. Epitranscriptomics in liver disease: Basic concepts and therapeutic potential. Journal of Hepatology 2020; 73(3) doi: 10.1016/j.jhep.2020.04.009
|
| 2 |
Xiaoming Yang, Siqi Sheng, Xingchen Du, Wentao Su, Jue Tian, Xunxia Zhao. Hepatocyte-specific TAZ deletion downregulates p62/ Sqstm1 expression in nonalcoholic steatohepatitis. Biochemical and Biophysical Research Communications 2021; 535 doi: 10.1016/j.bbrc.2020.12.038
|
| 3 |
Zhu Lin, Zhenkun Huang, Jiliang Qiu, Yunxing Shi, Dinglan Zuo, Zhiyu Qiu, Wei He, Yi Niu, Yunfei Yuan, Binkui Li. m6A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2024; 43(1) doi: 10.1186/s13046-024-03134-4
|
| 4 |
Christina-Maria Flessa, Ioannis Kyrou, Narjes Nasiri-Ansari, Gregory Kaltsas, Athanasios G. Papavassiliou, Eva Kassi, Harpal S. Randeva. Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives. Current Obesity Reports 2021; 10(2) doi: 10.1007/s13679-021-00431-3
|
| 5 |
Joost Willebrords, Isabel Veloso Alves Pereira, Michaël Maes, Sara Crespo Yanguas, Isabelle Colle, Bert Van Den Bossche, Tereza Cristina Da Silva, Cláudia Pinto Marques Souza de Oliveira, Wellington Andraus, Venâncio Avancini Alves, Bruno Cogliati, Mathieu Vinken. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Progress in Lipid Research 2015; 59 doi: 10.1016/j.plipres.2015.05.002
|
| 6 |
Kristen Stephenson, Lindsey Kennedy, Laura Hargrove, Jennifer Demieville, Joanne Thomson, Gianfranco Alpini, Heather Francis. Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights. Gene Expression 2018; 18(1) doi: 10.3727/105221617X15093707969658
|
| 7 |
Xuan Zha, Zewei Gao, Min Li, Xueli Xia, Zhenwei Mao, Shengjun Wang. Insight into the regulatory mechanism of m6A modification: From MAFLD to hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2024; 177 doi: 10.1016/j.biopha.2024.116966
|
| 8 |
Qi-Qi Dong, Yang Yang, Hui Tao, Chao Lu, Jing-Jing Yang. m6A epitranscriptomic and epigenetic crosstalk in liver fibrosis: Special emphasis on DNA methylation and non-coding RNAs. Cellular Signalling 2024; 122 doi: 10.1016/j.cellsig.2024.111302
|
| 9 |
Caroline C. Duwaerts, Jessica L. Maiers. ER Disposal Pathways in Chronic Liver Disease: Protective, Pathogenic, and Potential Therapeutic Targets. Frontiers in Molecular Biosciences 2022; 8 doi: 10.3389/fmolb.2021.804097
|
| 10 |
Jiawei Xu, Xingyu Liu, Shuqin Wu, Deju Zhang, Xiao Liu, Panpan Xia, Jitao Ling, Kai Zheng, Minxuan Xu, Yunfeng Shen, Jing Zhang, Peng Yu. RNA-binding proteins in metabolic-associated fatty liver disease (MAFLD): From mechanism to therapy. BioScience Trends 2023; 17(1) doi: 10.5582/bst.2022.01473
|
| 11 |
Kaiting Ning, Kaikai Lu, Qian Chen, Zizhen Guo, Xiaojuan Du, Farooq Riaz, Lina Feng, Yuping Fu, Chunyan Yin, Fujun Zhang, Litao Wu, Dongmin Li. Epigallocatechin Gallate Protects Mice against Methionine–Choline-Deficient-Diet-Induced
Nonalcoholic Steatohepatitis by Improving Gut Microbiota To Attenuate
Hepatic Injury and Regulate Metabolism. ACS Omega 2020; 5(33) doi: 10.1021/acsomega.0c01689
|
| 12 |
Jian Tan, Yue-fan Wang, Zhi-hui Dai, Hao-zan Yin, Chen-yang Mu, Si-jie Wang, Fu Yang. Roles of RNA m6A modification in nonalcoholic fatty liver disease. Hepatology Communications 2023; 7(2) doi: 10.1097/HC9.0000000000000046
|
| 13 |
Hoang Thu Trang Do, Simon Both, Tarek Kröhler, Marcello Pirritano, Elien Van Wonterghem, Elia Raab, Lisa Ahne, Sören Franzenburg, Emadeldin M Ibrahim, Martin Simon, Jeetayu Biswas, Volkhard Helms, Sonja M Kessler, Alexandra K Kiemer. HyperTRIBE identifies hepatic IGF2BP2/IMP2 targets in vivo and links IMP2 to autophagy. NAR Molecular Medicine 2026; 3(3) doi: 10.1093/narmme/ugag034
|
| 14 |
Azim Dehghani Amirabad, Pathmanaban Ramasamy, Marina Wierz, Karl Nordström, Sonja M. Kessler, Marcel H. Schulz, Martin Simon. Transgenic expression of the RNA binding protein IMP2 stabilizes miRNA targets in murine microsteatosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(10) doi: 10.1016/j.bbadis.2018.05.024
|
| 15 |
Beate Czepukojc, Ali Abuhaliema, Ahmad Barghash, Sascha Tierling, Norbert Naß, Yvette Simon, Christina Körbel, Cristina Cadenas, Noemi van Hul, Agapios Sachinidis, Jan G. Hengstler, Volkhard Helms, Matthias W. Laschke, Jörn Walter, Johannes Haybaeck, Isabelle Leclercq, Alexandra K. Kiemer, Sonja M. Kessler. IGF2 mRNA Binding Protein 2 Transgenic Mice Are More Prone to Develop a Ductular Reaction and to Progress Toward Cirrhosis. Frontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00179
|
| 16 |
Chad Pope, Shashank Mishra, Joshua Russell, Qingqing Zhou, Xiao-Bo Zhong. Targeting H19, an Imprinted Long Non-Coding RNA, in Hepatic Functions and Liver Diseases. Diseases 2017; 5(1) doi: 10.3390/diseases5010011
|
| 17 |
Mohamed Elbadawy, Megumi Yamanaka, Yuta Goto, Kimika Hayashi, Ryouichi Tsunedomi, Shoichi Hazama, Hiroaki Nagano, Toshinori Yoshida, Makoto Shibutani, Ryo Ichikawa, Junta Nakahara, Tsutomu Omatsu, Tetsuya Mizutani, Yukie Katayama, Yuta Shinohara, Amira Abugomaa, Masahiro Kaneda, Hideyuki Yamawaki, Tatsuya Usui, Kazuaki Sasaki. Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model. Biomaterials 2020; 237 doi: 10.1016/j.biomaterials.2020.119823
|
| 18 |
Zhenyu Xu, Bo He, Yongfang Jiang, Min Zhang, Yi Tian, Ning Zhou, Yanwen Zhou, Mengxuan Chen, Min Tang, Jiashi Gao, Feng Peng. Igf2bp2 knockdown improves CCl4-induced liver fibrosis and TGF-β-activated mouse hepatic stellate cells by regulating Tgfbr1. International Immunopharmacology 2022; 110 doi: 10.1016/j.intimp.2022.108987
|
| 19 |
Tarek Kröhler, Sonja M. Kessler, Kevan Hosseini, Markus List, Ahmad Barghash, Sonika Patial, Stephan Laggai, Katja Gemperlein, Johannes Haybaeck, Rolf Müller, Volkhard Helms, Marcel H. Schulz, Jessica Hoppstädter, Perry J. Blackshear, Alexandra K. Kiemer. The mRNA-binding Protein TTP/ZFP36 in Hepatocarcinogenesis and Hepatocellular Carcinoma. Cancers 2019; 11(11) doi: 10.3390/cancers11111754
|
| 20 |
Junguo Cao, Weijia Yan, Xiujian Ma, Haiyan Huang, Hong Yan. Insulin-like Growth Factor 2 mRNA-Binding Protein 2—a Potential Link Between Type 2 Diabetes Mellitus and Cancer. The Journal of Clinical Endocrinology & Metabolism 2021; 106(10) doi: 10.1210/clinem/dgab391
|
| 21 |
Lijiao Sun, Xin Chen, Sai Zhu, Jianan Wang, Shaoxi Diao, Jinyu Liu, Jinjin Xu, Xiaofeng Li, Yingyin Sun, Cheng Huang, Xiaoming Meng, Xiongwen Lv, Jun Li. Decoding m6A mRNA methylation by reader proteins in liver diseases. Genes & Diseases 2024; 11(2) doi: 10.1016/j.gendis.2023.02.054
|
| 22 |
J. Jose Corbalan, Pranavi Jagadeesan, Karla K. Frietze, Rulaiha Taylor, Grace L. Gao, Grant Gallagher, Joseph T. Nickels. Humanized monoacylglycerol acyltransferase 2 mice develop metabolic dysfunction-associated steatohepatitis. Journal of Lipid Research 2024; 65(12) doi: 10.1016/j.jlr.2024.100695
|
| 23 |
Naqash Alam, Xinhua Ding, Yu Fu, Linying Jia, Sadiq Ali, Enqi Liu. Oryzanol ameliorates MCD-induced metabolic dysfunction-associated steatohepatitis in mice via gut microbiota reprogramming and TLR4/NF-κB signaling suppression. American Journal of Physiology-Gastrointestinal and Liver Physiology 2025; 328(5) doi: 10.1152/ajpgi.00190.2024
|
| 24 |
Vera H. I. Fengler, Tanja Macheiner, Sonja M. Kessler, Beate Czepukojc, Katja Gemperlein, Rolf Müller, Alexandra K. Kiemer, Christoph Magnes, Johannes Haybaeck, Carolin Lackner, Karine Sargsyan, Pavel Strnad. Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease. PLOS ONE 2016; 11(5) doi: 10.1371/journal.pone.0155163
|
| 25 |
S M Kessler, S Laggai, A Barghash, C S Schultheiss, E Lederer, M Artl, V Helms, J Haybaeck, A K Kiemer. IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype. Cell Death & Disease 2015; 6(10) doi: 10.1038/cddis.2015.241
|
| 26 |
Sophie C. Cazanave, Arun J. Sanyal. Hepatic De Novo Lipogenesis and Regulation of Metabolism. 2016; doi: 10.1007/978-3-319-25065-6_5
|
| 27 |
Robert Schierwagen, Lara Maybüchen, Sebastian Zimmer, Kanishka Hittatiya, Christer Bäck, Sabine Klein, Frank E. Uschner, Winfried Reul, Peter Boor, Georg Nickenig, Christian P. Strassburg, Christian Trautwein, Jogchum Plat, Dieter Lütjohann, Tilman Sauerbruch, Frank Tacke, Jonel Trebicka. Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis. Scientific Reports 2015; 5(1) doi: 10.1038/srep12931
|
| 28 |
Muhua Yang, Christina Gallo-Ebert, Michael Hayward, Weidong Liu, Virginia McDonough, Joseph T. Nickels.
Human Insulin Growth Factor 2 mRNA Binding Protein 2 Increases MicroRNA 33a/b Inhibition of Liver
ABCA1
Expression and Alters Low-Density Apolipoprotein Levels in Mice
. Molecular and Cellular Biology 2020; 40(16) doi: 10.1128/MCB.00058-20
|